Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE

Askanase, A. D., Tang, W., Zuraw, Q., Gordon, R., Brotherton, B., & Merrill, J. T. (2023). Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE. Lupus Science & Medicine, 10(1), e000875. https://doi.org/10.1136/lupus-2022-000875
Authors:
Anca Askanase
Wei Tang
Qing Zuraw
Robert Gordon
Betsy Brotherton
Joan T. Merrill
Affiliated Authors:
Anca Askanase
Columbia Affiliation:
Subjects:
Ustekinumab (MeSH)
Lupus Erythematosus, Systemic (MeSH)
Systemic Lupus Erythematosus and Antiphospholipid Syndrome (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Pharmacological Effects of Licorice Roots (OpenAlex Topic)
Author Keywords:
arthritis
lupus erythematosus, systemic
outcome assessment, health care
therapeutics
elink
Publication Type:
Article
Unique ID:
10.1136/lupus-2022-000875
PMID:
37012059
DOI:
10.1136/lupus-2022-000875
Journal:
Lupus Science and Medicine
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: